Pegylated Liposomal Doxorubicin Is an Active Agent for Chemotherapy-Resistant Choriocarcinoma: A Report of Two Cases.

@article{Popadiuk2016PegylatedLD,
  title={Pegylated Liposomal Doxorubicin Is an Active Agent for Chemotherapy-Resistant Choriocarcinoma: A Report of Two Cases.},
  author={Catherine Popadiuk and Patti Power},
  journal={The Journal of reproductive medicine},
  year={2016},
  volume={61 5-6},
  pages={215-8}
}
BACKGROUND Despite advances in chemotherapy, radiation, surgery, and supportive treatments, a significant proportion of high-risk metastatic gestational trophoblastic disease patients develop resistant disease and die. Of those cured, protracted treatments can lead to long-term morbidity or later toxicity and death. Here we describe 2 patients with brain… CONTINUE READING